As returns on market increase, Medgenics returns are expected to increase less than the market. However during bear market, the loss on holding Medgenics will be expected to be smaller as well.
Stephen Bellomo VP - Program Management and Product Development; COO of Medgenics Medical (Israel) Limited
Medgenics Price and Market Media
The median price of Medgenics for the period between Wed, Apr 24, 2013 and Fri, May 24, 2013 is 4.1 with a coefficient of variation of 3.15. The daily time series for the period is distributed with a sample standard deviation of 0.13, arithmetic mean of 4.11, and mean deviation of 0.11. The Stock received some media coverage during the period.
Medgenics Inc [MDGN] is traded on American Stock Exchange in USA. It is located in Medgenics, Inc.San Francisco, CA and employs 34 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 71.89 M. Medgenics Inc has 18.48 M outstanding shares of which 359.17 K shares are now shorted by private and institutional investors with about 7.3 trading days to cover.
Medgenics, Inc., a medical technology and therapeutics company, engages in the research and development of solutions in the field of biotechnology and associated medical equipment in the United States. more
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory